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ABSTRACT We performed in silico modeling of the regulatory network of mitochondrial apoptosis through which we examined
the role of a Bax-activation switch in governing the mitochondrial apoptosis decision. Two distinct modeling methods were used
in this article. One is continuous and deterministic, comprised of a set of ordinary differential equations. The other, carried out in
a discrete manner, is based on a cellular automaton, which takes stochastic ﬂuctuations into consideration. We focused on dynamic
properties of the mitochondrial apoptosis regulatory network. The roles of Bcl-2 family proteins in cellular responses to apoptotic
stimuli were examined. In our simulations, a self-ampliﬁcation process of Bax-activation is indicated. Further analysis suggests
that the core module of Bax-activation is bistable in both deterministic and stochastic models, and this feature is robust to noise
and wide ranges of parameter variation. When coupling with Bax-polymerization, it forms a one-way-switch, which governs ir-
reversible behaviors of Bax-activation even with attenuation of apoptotic stimulus. Together with the growing biochemical
evidence, we propose a novel molecular switch mechanism embedded in the mitochondrial apoptosis regulatory network and
give a plausible explanation for the all-or-none, irreversible character of mitochondrial apoptosis.
INTRODUCTION
Systems biology is a hybrid experimental-computational ap-
proach. It takes a systemic view of cellular transactions caused
by the interaction of the basic components of the cell. As an
integral part of systems biology, mathematical modeling
provides a unique opportunity for interweaving the individ-
ual molecules into an in silico fabric and dissecting complex
networks into small elementary modules, thus helping to un-
cover the kinetic essences of different cellular transactions
such as adaptations, oscillations, and switchlike phenomena
(1–3). Various modeling methods have been implemented in
recent years, including continuous ones employing numer-
ical treatment of cellular information processing and discrete
ones with excellent simplicity as well as scalability. Some of
these methods are fully deterministic (4–6), while others have
introduced noise (7–10).
Apoptosis is an all-or-none, irreversible physiological pro-
cess through which the cell commits suicide when respond-
ing to various apoptotic stimuli (11,12). Once a cell has
passed a certain checkpoint, it is fated to undergo apoptosis
even after the stimulus has been withdrawn (13). These char-
acteristics are believed to arise out of the apoptosis regula-
tory network.
Various models have focused on the mechanisms of apo-
ptosis induction and have provided some elegant explana-
tions. Bentele et al. (14) developed a model to explore the
threshold mechanism for the regulation of CD95-induced
apoptosis while Eissing et al. (15) modeled the process of
receptor-induced apoptosis to show that interference of in-
hibitor of apoptosis (IAP and BAR) constitutes a bistable
module. Another model raised by Bagci et al. (16) has dem-
onstrated bistability caused by kinetic cooperativity in the
formation of the apoptosome complex during mitochondria-
dependent pathways. These models mainly focus on mito-
chondria-independent apoptosis, or concentrate on caspases
which act downstream of mitochondria. However, little at-
tention has been paid to mitochondrial regulatory events. It is
widely recognized that mitochondrial regulatory events have
priority in the cell fate decision. Mitochondrial outer mem-
brane permeabilization (MOMP), which represents the ‘‘point
of no return’’ of cell death, can commit a cell to die even
when caspases are not activated (17). This raises the impor-
tance of uncovering the mechanism of mitochondrial reg-
ulatory events that play the crucial role in the apoptotic
decision process. Another problem concerns the modeling
methods. Models mentioned above are mostly based on or-
dinary differential equations (ODEs), which are deterministic
descriptions in terms of concentrations and can only describe
the average behavior of a system based on large populations.
Also, the mass action law that underlies kinetic formulae is
an approximation in which concentrations are assumed low
enough to ignore the size of the molecules. It is now widely
recognized that low copy numbers of molecules and mac-
romolecular crowding effects in physiological conditions have
to be taken into account in more realistic models (8,18).
Recently, there has been an accelerating interest in the in-
vestigation of these effects in biological regulation through
various kinds of stochastic modeling methods (10,19). Siehs
et al. (20) did a pioneering job to simulate the apoptosis
reaction network at mesoscale. They presented a cellular
automaton (CA)-based simulation framework named Lattice
Molecular Automaton (LMA), and successfully performed
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discrete modeling of the role of interactions of Bcl-2 family
proteins in governing the apoptosis decision. As they sug-
gested, growing experimental knowledge about the apoptosis-
relevant proteins would help to improve the model and further
elucidate the regulatory mechanisms of apoptosis induction.
In this article, we translate acquired biological knowledge
of the mitochondrial apoptosis regulatory network into math-
ematical models, in particular focusing on the regulatory
events at the mitochondrial level. Two distinct modeling ap-
proaches were used for different purposes. Modeling by de-
terministic ODEs is convenient for bifurcation analysis and
parameter discussion, while stochastic ﬂuctuations and mac-
romolecular crowding effects in cellular conditions are taken
into account by stochastic CA modeling. Simulation results
of these two methods support each other and reveal that a
core module of Bax-activation is capable of displaying
bistable behavior and forms a toggle-switch (bidirectional
switch). With cooperation of Bax-polymerization, it changes
to a one-way switch, strongly improving its robustness against
stochastic ﬂuctuations. Our simulation results, together with
growing biochemical evidence, indicate that the bistable
module of Bax-activation coupling with Bax-polymerization
can form a bioswitch robust enough to govern the decision of
mitochondrial apoptosis under noisy physiological conditions.
BIOLOGICAL BACKGROUND
Apoptosis is a well-regulated process, which is essential for
tissue remodeling and homeostasis of multicellular orga-
nisms (21). Mitochondria play a crucial role in apoptosis by
sensing incoming apoptotic signals and respond by mito-
chondrial outer membrane (MOM) permeabilization. Then,
apoptogenic factors such as cytochrome c, Smac/DIABLO,
and Omi/Htra 2 are released from the mitochondrial inter-
membrane space into the cytosol and nucleus, where they
trigger caspase activation cascades and other cell-death events
(22).
Although the exact molecular mechanism of MOMP is not
elucidated, most experimental evidence indicates that MOMP
is mainly governed by intricate interactions among Bcl-2
family proteins that possess either pro- or anti-apoptotic
activities (23). The pro-apoptotic members are divided into
two groups: the Bax group (Bax, Bak, and Bok) possesses
BH1-3 domains, whereas the BH3-only proteins (Bid, Bad,
Bim, Bik, Bmf, Puma, Noxa, and Hrk) share only the BH3
domain. The anti-apoptotic members as Bcl-2 and Bcl-xL
contain all BH domains. In resting cells, some Bcl-2 family
proteins (Bcl-2, Bcl-xL, and Bak) are targeted to MOM and
other intracellular membranes, while others (BH3 only proteins,
Bax) predominantly exist as soluble monomers or are seques-
tered by a number of non-Bcl-2 proteins in the cytosol (24).
Here we present a picture of the regulatory network of
mitochondrial apoptosis (Fig. 1), which is mainly based on a
switched rheostat model for the roles of Bcl-2 family pro-
teins in regulating MOMP (25). Although it is reported that
the occurrence of MOMP is sometimes independent of Bax,
this is beyond the scope of our discussion in this article. Key
events of our model were described as follows.
Translocation of Bcl-2 family proteins from
cytosol to MOM
In response to apoptotic stimuli, Bax monomers as well as
BH3-only proteins translocate from the cytosol to MOM
(24,26). Although the molecular mechanisms underlying these
events remain incompletely understood, relocation of Bcl-2
family proteins from the cytosol to MOM can be regarded as
the initial event of MOMP and apoptosis induction.
Activation of Bax and/or Bak
Recent evidence supports that select BH3-only proteins (Bid,
Bim), which can be designated as ‘‘Activator,’’ are sufﬁcient
to enable a conformational change and pore formation of
Bax/Bak (for general designation we use ‘‘Bax’’) through
direct interaction with them (23,27,28). Anti-apoptotic family
members (described as ‘‘Bcl2’’ for a general designation)
can act as inhibitors by interacting with Activator and acti-
vated Bax (25,29–31). Other BH3-only proteins (Bad, Bik,
Bmf, PUMA, Noxa, and Hrk) can act as ‘‘Enabler’’ by bind-
ing competitively to the anti-apoptotic family members, thus
liberating the Activator and activated Bax (23,32). Activated
Bax can spontaneously fall back to the inactive form, and
perhaps relocate from MOM to the cytosol (13,33).
Pore formation and release of apoptogenic factors
The formation of mitochondrial apoptosis-induced channels
(MAC) is thought to be the endpoint of the MOMP regu-
latory network (34). According to a report of Saito et al (35),
activated Bax monomers can aggregate into tetramers to form
FIGURE 1 Outline of mitochondrial apoptosis regulatory network. We
mainly focus on the roles of Bcl2 family proteins in regulating MOMP.
Abbreviations of molecule names listed in Table 2 are used for clarity (e.g.,
Enabler (Ena), Activator (Act), inactive Bax (InBax), activated Bax (AcBax),
etc.). Solid arrows denote reactions; dotted arrows describe subcellular trans-
location or upregulation; and those terminated by a bar denote interaction
and inhibition. The dashed region indicates the core module of Bax activation.
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the protein-conducting channels. Furthermore, apoptosis-
induced Bax/Bak clusters localized to MOM can be visu-
alized by immunoelectron microscopy and they are tested to
be responsible for MOMP (36). It is now widely accepted
that Bax clusters consisting of four or more Bax monomers is
responsible for conducting apoptotic factors such as cyto-
chrome c. Moreover, the permeability of some constitutive
channels (CC) on MOM, e.g., the voltage-dependent anion-
selective channel (VDAC), can be regulated by Bcl-2 family
members (37,38). Bax may trigger its conformational change
resulting in VDAC opening for apoptogenic factors, while
Bcl2 may have the opposite function.
MODEL AND METHODS
ODEs modeling
We developed a reduced model realizing mass action kinetics implemented
as a set of ODEs, which is based on a simpliﬁed description of the mitochon-
drial apoptosis regulatory network. The ODE model can be dissected into
three parts as follows:
1. Relocation of Bcl-2 family proteins from cytosol to MOM as initial
signal. We suppose that the concentrations of Bax, Activator, and Bcl2
on the MOM increase linearly with the apoptotic stimulus, while details
such as expression, degradation, and posttranslational regulation are not
considered for reasons of simplicity (see Eqs. 1–4). F stands for the
strength of the combined initial stimuli comprised of three parts, F1, F2,
and F3, which describe the effects of stimuli on the translocation of Bax,
Activator, and Bcl2, respectively. The initial concentrations on MOM
added to the translocated parts make up the mitochondrial concentra-
tions of Bax, Activator, and Bcl2 (Baxmito, Actmito, and Bcl2mito as indi-
cated below), and the concentrations of translocated parts are in proportion
to the stimuli F. Baxmito, Actmito, and Bcl2mito are assumed to be con-
stant during our simulations. Baxcytosol, Actcytosol, and Bcl2cytosol re-
present the concentrations of Bax, Activator, and Bcl2 in the cytosol,
respectively:
F ¼ ðF1;F2;F3Þ; F1;F2;F3 2 ½0; 1 (1)
Baxmito ¼ Baxinitial1Baxcytosol  F1 (2)
Actmito ¼ Actinitial1Actcytosol  F2 (3)
Bcl2mito ¼ Bcl2initial1Bcl2cytosol  F3: (4)
2. Interaction network of Bcl-2 family proteins including: (a), activation of
Bax by Activator in a kiss-and-run manner (23,27,28); (b), the inhibi-
tion of Activator and activated Bax by heterodimerization with Bcl2;
and (c), a possible process in which activated Bax can replace Activator
from Bcl2. The kinetics of these processes is described by the reactions
and rate constants in Table 1. The rate equations of activated Bax mono-
mer, free Activator, and free Bcl2 (the concentrations are indicated a




¼ k5  ½Act  ½Bcl21 k6  ½ActBcl2
1 k7  ½AcBax  ½ActBcl2
 k8  ½Act  ½AcBaxBcl2; (6)
d½Bcl2
dt
¼ k3  ½AcBax  ½Bcl2  k5  ½Act  ½Bcl2
1 kbcl2  ½Bcl2nonfree; (7)
where [Bcl2nonfree] indicates the total concentration of Bcl2 associated with
both activated Bax and Activator ([Bcl2nonfree]¼ [AcBaxBcl2]1 [ActBcl2]).
We use kbcl2 to represent the rate of non-free Bcl2 shifting to free Bcl2,
assuming that free Bcl2 originates from both Bcl2 non-free forms at the same
rate. Also, the concentrations of proteins referred above should obey the
following equations because of mass conservation:
TABLE 1 Reactions and relative rate constants of ODEs
modeling of the regulatory network of mitochondrial apoptosis
Description of reactions
Act 1 InBax /k1 Act 1 AcBax
AcBax /k2 InBax
AcBax 1 Bcl2 k4 k3 AcBaxBcl2
Act 1 Bcl2 k6 k5 ActBcl2
AcBax 1 ActBcl2 k8 k7 Act 1 AcBaxBcl2
4 AcBax k10 k9 Bax4
with
Rate constants Initial conditions
k1 ¼0.5 mM1 s1 Actmito ¼ 0 3 104 mM
k2 ¼ 0.1 s1 Baxmito ¼ 2 3 104 mM
k3 ¼ 2 mM1 s1 Bcl2mito ¼ 1 3 104 mM
k4 ¼ 0.001 s1 Actcytosol ¼ 1 3 104 mM
k5 ¼ 3 mM1 s1 Baxcytosol ¼ 2 3 104 mM
k6 ¼ 0.04 s1 Bcl2cytosol ¼ 0 3 104 mM
k7 ¼ 2 mM1 s1
k8 ¼ 0 mM1 s1
k9 ¼ 2 mM1 s1
k10 ¼ 0 s1
For clarity, abbreviations in Table 2 are used for description of reactions.
We set kbcl2 (the rate of non-free Bcl2 shifting to free Bcl2; for details, see
Model and Methods) equal to k6 assuming that free Bcl2 originate from
AcBaxBcl2 at the same rate with ActBcl2. The parameter k1, k3, k4, k5, k6,
k8, and k9 are set up to with one order-of-magnitude difference with respect
to those used by Hua et al. (43) in their modeling of the effects of Bcl2-level
on Fas signaling-induced caspase-3 activation. The ratio of k3 to k4 ensures
an equilibrium constant of 1e-8M from (32), as well as those used for
deﬁning k5 and k6. The value of k2, k7, and k8 are suitably chosen to reﬂect
the experimentally known features (13,32,33). To reﬂect the irreversibility
of the process of Bax-polymerization (35), k10 is step to 0 in our simu-
lations. The concentrations of relative Bcl-2 family proteins in initial
conditions are set up according to experimental data given by Kuwana et al.
(42) and with one order-of-magnitude difference with respect to those used
by Hua et al. (43).
d½AcBax
dt
¼ k1  ½Act  ½InBax  k2  ½AcBax
 k3  ½AcBax  ½Bcl21 k4  ½AcBaxBcl2
 k7  ½AcBax  ½ActBcl21 k8  ½Act  ½AcBaxBcl2; (5)
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½InBax1 ½AcBax1 ½AcBaxBcl2 ¼ Baxmito; (8)
½Act1 ½ActBcl2 ¼ Actmito; (9)
½Bcl21 ½AcBaxBcl21 ½ActBcl2 ¼ Bcl2mito: (10)
According to Eqs. 8–10, substitutions and simpliﬁcations can be
made for Eqs. 5–7, which ultimately employ [AcBax], [Act], and [Bcl2]
as three variables of the differential equations. Equations 1–10 together
give the mathematical representation of the core module of Bax-activation.
3. Bax-polymerization. Although the complete molecular identity of MAC
is yet to be determined, activated Bax monomers are believed to aggre-
gate into clusters that could represent protein-conducting pores (34,35).
In our extended model considering Bax-polymerization, we suppose
that tetramers are the sole form of Bax polymers equating to MAC. We
use the following differential equation describing the kinetics of Bax
tetramers (the concentration of Bax tetramers is indicated as [Bax4], and
the cooperative coefﬁcient of Bax polymerization n is set to be 3):
d½Bax4
dt
¼ k9  ½AcBaxn  k10  ½Bax4: (11)
Correspondingly, Eq. 5 describing the kinetics of activated Bax
monomer and Eq. 7 describing the conservation of Bax are modiﬁed as
follows:
½InBax1 ½AcBax1 ½AcBaxBcl21 4  ½Bax4 ¼ Baxmito:
(89)
All the differential equations listed above were solved mathematically
using the ODE23s routine of MatLab 6.5 (The MathWorks, Natick, MA).
The simulation programs were written in M ﬁles, with commonly used
MatLab subroutines. Bifurcation analysis was performed by using the sub-
programAUTO contained in XPPAUT 5.91 (http://www.math.pitt.edu/;bard/
xpp/xpp.html, Department of Mathematics, the University of Pittsburgh).
CELLULAR AUTOMATON
ODEs modeling usually has remarkable predictive power at macroscale
levels, where molecules essentially lose their discreteness and become
inﬁnitely small and numerous. However, it always generates smooth curves
that fail to capture the granularity or stochasticity of living systems. An
alternative concept named the cellular automaton (CA) is presented here and
speciﬁcally tailored to model mitochondrial apoptosis regulatory network.
Its value for simulations of biological processes has been discussed
previously (9,39). The crucial feature of the CA devised here is that it utilizes
Brownian motion, which dominates over all other forces at mesoscale levels
to mimic the movement of molecules on the MOM. A model considering all
elements in Fig. 1 was carried out as a CA implementation, which is described
as follows:
System representation
The MOM is realized on a two-dimensional, square lattice (four neighbors)
with periodic boundaries. Each lattice site can contain a restricted number of
molecules, according to the excluded volume effects in cellular conditions
(40). Molecules are uniformly distributed on the lattice at the beginning of
the simulation. They are supposed to be identical in size, but different
weights that inﬂuence the abilities of molecules to move are taken into
account. Characteristics of the various molecules are described in Table 2.
Brownian motion
In our implementation, the motions of all molecules are performed in a
stepwise fashion. In each movement cycle, every molecule is ﬁrst given a
probability check, which determines whether it moves at this particular step
due to its velocity (indicated by probability of movement in a step, given in
the interval [0,100]; a velocity constant V ¼ 50 means that the molecule has
a probability P ¼ 50:100 ¼ 0.5 to move to a neighboring site per updated
step). If a molecule is determined to be stationary in the probability check, an
integer 0 is given to its movement direction. Otherwise, a random integer
between 1 and 4, which indicates possible directions (up, down, left, and
right, respectively) is designated. Next it passes a volume check to avoid
violating the exclusion principle. A randomly chosen new direction is
reassigned if its forth-going site has already been occupied completely. A
movement step is ﬁnally performed and all molecules are moved according
to their assigned velocities and directions.
Reaction rules
Reactions take place between two molecules occupying the same lattice site
at a particular time step and follow simple pairwise interaction rules. If more
than two molecules occupy a site, the reaction sequence is chosen in a
random fashion. Reactions and rules are shown in Table 3, where the
reaction rate constants are indicated by probabilities given in the interval
[0,1000]. A reaction rate constant K ¼ 500 means that probability of the
reaction is P¼ 500:1000¼ 0.5 per update step. Most reactions in our model
are reversible. So, for molecules like dimers, a course of dissociation is
included and a set of dissociation constants is embraced in the rules table. An
exclusion check is employed to prevent extreme conditions when the
designation of new molecules originated from old ones would violate the
exclusion principle.
The CA modeling was implemented on a personal computer running
Windows XP. Microsoft Visual Basic 6.0 was used as the programming
language.
RESULTS AND DISCUSSION
Modeling of the mitochondrial apoptosis
regulatory network
In our previous studies, we have constructed a simpliﬁed
CA-based model of the mitochondrial apoptosis regulatory
network, focusing particularly on two major mechanisms of
how Bcl-2 family proteins regulate MOMP (41). Consistent
with experimental results, our studies reveal that the
d½AcBax
dt
¼ k1  ½Act  ½InBax  k2  ½AcBax  k3  ½AcBax  ½Bcl2
1 k4  ½AcBaxBcl2  k7  ½AcBax  ½ActBcl21 k8  ½Act  ½AcBaxBcl2
 4  k9  ½AcBaxn1 4  k10  ½Bax4 (59)
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concentration of Bax and the Bcl-2 to Bax ratio are key
factors for controlling the MOMP and apoptosis. Here we
extended this model by introducing more elements of the
mitochondrial apoptosis regulatory network demonstrated in
Fig. 1. The initial nonapoptotic condition of the mitochon-
drial system was simulated ﬁrst and apoptotic stimuli were
added to the system subsequently.
Initial nonapoptotic condition
We constructed the CA model at the single mitochondrion
level. A grid of 1003100 squares is used to represent the
outer membrane of the mitochondrion (;4 mm2, calculated
from the average size of a mitochondrion, so the size of each
square is 20 nm 3 20 nm). According to the excluded-
volume effects, each square is restricted to containing ﬁve
membrane proteins at most (as the diameter of membrane
proteins is ;5–10 nm). Previous studies reveal that Bcl-2
family proteins have different concentrations in different cells
as well as in different subcellular compartments (13,42).
Kuwana et al. (42) calculated that tumor cells typically
contain 200–600 nM Bax; other estimated concentrations are
25, 75, and 83 nM for Bid, Bcl2, and Bax, respectively (43).
Some reports determined certain important ratios, such as
Bcl-2 to Bax, which are critical for regulating the release of
cytochrome c from the mitochondria (44,45). In particular,
Childs et al. (46) quantiﬁed the amounts of mitochondrial
Bcl-2 and Bax in rat cardiomyocytes using ELISAs and
found that the ratio of Bcl-2/Bax is ;1.17, which is lifted to
1.41 upon administration of doxorubicin. Furthermore, esti-
mating a cell volume of 1 picoliter shows that 1 nM ¼ 600
molecules per cell, and according to Robin and Wong, a typ-
ical mammalian cell contains approximately several hundred
mitochondria. Partly based on these data (the concentrations
of relevant proteins, the average volume per cell, and the
average number of mitochondria per cell), we made a rough
estimate that there are 1600 Bcl2, 800 InBax, 200 Activator,
80 Enabler, 80 CC, and 3200 other proteins on the outer
membrane of a mitochondrion in resting cells. These ‘‘Other’’





Act Activator 1 67
Bcl2 Bcl2 1 67
Ena Enabler 1 67
ActBcl2 Heterodimer of Activator
and Bcl2
2 50
EnaBcl2 Heterodimer of Enabler
and Bcl2
2 50
InBax Inactive Bax 1 67
AcBaxm Activated Bax monomer/polymer
(m represents the degree of
polymerization of AcBax, e.g.,
m ¼ 2 represent dimer of activated
Bax, m can be omitted when m ¼ 1)
m 0;67
AcBaxBcl2 Heterodimer of Activated Bax
and Bcl2
2 67
CC Constitutive channel 20 9
AcBaxCC Activated Bax and Constitutive
Channel Complex
21 9
Bcl2CC Bcl2 and Constitutive Channel
Complex
21 9
Other Other molecules which have no
reactions with Bcl-2 family proteins
1 67
Molecular weights of various kinds of proteins are assigned to discriminate
the moving abilities of different molecules. The weights of Act, Bcl2, Ena,
InBax, and Other are set up to 1, and the weights of CC is assigned a value
bigger than Act, Bcl2, Ena, InBax, and Other according to experimental
observations by Verrier et al. (37). Through calculating we can get the
weights of other molecules like heterodimers and homopolymers. Molec-
ular velocities (V) are assumed to be in inverse proportion to molecular
weights (W) and they are calculated from V ¼ 100/(1 1 W/A), where
parameter A is used to regulate the inverse proportion relationship between
W and V. We set A ¼ 2 in our simulation and the values of relative
molecules are listed in the velocities column of Table 2.
TABLE 3 Rules table of CA modeling of regulatory network of
mitochondrial apoptosis
Descriptions of reactions
Act 1 InBax /K1 Act 1 AcBax
AcBax /K2 InBax
AcBax 1 Bcl2 K4K3 AcBaxBcl2
Act 1 Bcl2 K6K5 ActBcl2
AcBax 1 ActBcl2 K8K7 Act 1 AcBaxBcl2
AcBaxm 1 AcBaxn K10K9 AcBax (m1n)*
Ena 1 Bcl2 K12K11 EnaBcl2
AcBax 1 EnaBcl2 K14K13 Ena 1 AcBaxBcl2
Ena 1 ActBcl2 K16K15 Act 1 EnaBcl2
AcBax 1 CC K18K17 AcBaxCC
Bcl2 1 CC K20K19 Bcl2CC
AcBax 1 Bcl2CC K22K21 AcBaxCC 1 Bcl2
With
Rate constants
K1 ¼ 200 K10d ¼ 2 K17 ¼ 350
K2 ¼ 6 K10t ¼ 1 K18 ¼ 1
K3 ¼ 400 K11 ¼ 500 K19 ¼ 400
K4 ¼ 2 K12 ¼ 1 K20 ¼ 1
K5 ¼ 500 K13 ¼ 150 K21 ¼ 10
K6 ¼ 1 K14 ¼ 150 K22 ¼ 150
K7 ¼ 250 K15 ¼ 250
K8 ¼ 150 K16 ¼ 15
An AcBax polymer can react with another to produce a lager AcBax
polymer. In realistic reaction systems, the rate constants of Bax dimeriza-
tion, trimerization, etc. must be different. We here make a simple
assumption that larger polymers of AcBax are more likely to polymerize
and the set of rate constants are deﬁned by K9 ¼ 1000 3 (m1n)/
(B1(m1n)). Here m, n, and m1n are molecular weights of these polymers;
B is a parameter to regulate the relationship between K9 and (m1n). We
adopt B ¼ 10 to make the value of K9 comparable to other rate constants
used in our CA simulation. Bax dimers and trimers are supposed to be able
to dissociate and the dissociation constants are deﬁned as K10d and K10t,
respectively. The formation of larger Bax polymers is supposed to be
irreversible. The parameters K1 to K9, K10d, and K10t are chosen to preserve
the main ratio relationships among them in ODEs modeling. According to
this set of parameters, K11 to K22 are chosen in such a way to realize stable
dynamics on the simulation grid of our CA model as described by Siehs
et al. (20).
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proteins help to simulate the crowded condition on MOM.
Molecules are randomly scattered on the grid and after rapid
diffusion and reactions, the system arrives at an equilibrium
state that represents the initial condition of MOM in non-
apoptotic cells.
Fig. 2 gives a snapshot showing the molecular information
when the equilibrium state is achieved. Enabler and Activa-
tor are mostly sequestered by Bcl2 (Fig. 3 a, 0–1000 steps).
The total number of Bax pores and active CCs are used to
represent the occurrences of MOMP and apoptosis. Neither
Bax pore (Bax tetramers and larger clusters) nor active CC
(AcBaxCC) is found in this state (Fig. 3 b, the dotted line and
dashed line, respectively, 0–1000 steps).
Simulating apoptosis induction
The amount of translocated Bcl-2 family proteins from the
cytosol to MOM is used to represent the direct signal of
apoptosis. Fig. 3, a–c, illustrates the effect of apoptotic
signals on the homeostasis of the MOM system. At step 1000
the combined signal (including 2400 Bax, 250 Activator, and
120 Enabler) diffuses rapidly into the system. The number of
Activator molecules decreases sharply after translocation
because of Bcl2 sequestration (Fig. 3 a, solid line), but rises
and maintains a high level in the next 3000 steps before
falling down again, as does the Enabler (Fig. 3 a, dotted
line). The number of AcBax monomers ﬁrst rises sharply
because of rapid activation (Fig. 3 b, solid line), but de-
creases because of Bcl2 sequestration later on. Then it rises
again and maintains a relative high level. As AcBax ag-
gregates into clusters at a later stage (Fig. 3 b, dotted line),
the number of AcBax monomers ﬁnally drops. The amount
of Bcl2 decreases at the early stage because of binding with
both Activator/Enabler and AcBax monomers. However,
after Bax-polymerization, Bcl2 is restored to a higher level
(Fig. 3 c) and most Activator/Enabler molecules are seques-
tered again by Bcl2 (Fig. 3 a, second decrease). For compar-
ison, similar kinetics of these molecules is plotted in Fig. 3,
c–e, with a standard best-ﬁt ODE modeling of these reac-
tions. Notice that the CA kinetic curve displays stochasticity
(or noise) compared to the one calculated by solving the
ODEs. This stochasticity must be due to the randomness of
molecule collisions when using a particle-based method,
such as CA. Another reason for stochasticity is the revers-
ibility of these reactions considered in our CA modeling. A
slight difference between the curves of Bax pore exists in
Fig. 3, b and e, because the processes of Bax polymerization
are modeled using different expressions in CA and ODE
model, respectively.
As shown in Fig. 3 b, after apoptosis induction, the
number of Bax pores increases remarkably in contrast to
active CCs. In this simulation, Bax pores constitute the major
parts of the MACs, while active CCs play a negligible role.
This is consistent with most experimental reports (34). How-
ever, in some reports active CCs such as VDAC and/or
permeability transition pore complex have a dominant role
in controlling MOMP (26,47,48). For example, in ethanol-
induced apoptosis of rat hepatocytes, Bax was not found
oligomerized but interacted with the mitochondrial channel
protein VDAC, which is responsible for cytochrome c re-
lease and apoptosis (49). We do not yet knowmuch about the
molecular basis of the origin of these different behaviors. A
natural explanation could be that the concentrations of rele-
vant proteins are different in various cell and stimulus con-
ditions. Our model provides opportunities to examine and
test whether this assumption can work in theory. We changed
the initial ratio of Bax to CC and relevant parameters in our
simulation and consequently reversed the ratio of Bax pores
to active CCs (Fig. 4). Here changing the reaction rate is
equivalent to changing the concentrations of relative pro-
teins. These results indicate that certain contradictory experi-
mental results about the mechanism of MOMPmay be due to
different ratios of relevant proteins and parameters in various
cell conditions. Nevertheless, we should admit that what
we have proposed here is just a possible explanation and to
further validate it, special examination of the concentrations
of molecules and related wet-lab experiments under different
conditions are needed.
We can also change the concentrations of molecules to
study the roles of different Bcl-2 family proteins in the cell
response to apoptotic stimuli. For instance, a twofold in-
crease in the concentration of Bcl2 on MOM is used as initial
condition in contrast to those in Fig. 3, a–c. Neither Bax pore
nor active CC is observed during the whole simulation time-
scale (data not shown). So, we can conclude that in our
model, a twofold increase in the concentration of Bcl2 on
MOM can result in resistance to MOMP. This is consistent
FIGURE 2 Snapshot of the CA simulation grid showing the coverage of
different molecules when an equilibrium state of initial condition (non-
apoptotic cells) is achieved. Given is only a section of the grid of 1003100
squares. Overlapping colors indicates that more than one molecule occupy a
same lattice site at this particular time step. Molecules are indicated by
distinct colors and shapes as described on the left. Abbreviations of molecule
names listed in Table 2 are used for clarity.
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with experimental reports in which Bcl-2 overexpressing
cells are usually apoptosis-resistant (31,50). In our previous
simpliﬁed model, by varying the concentrations of Bax and
the Bcl-2-to-Bax ratio, these two factors were suggested to
be key factors in regulating MOMP (41). Furthermore, the
interaction rules of our CAmodel can be modiﬁed to perform
experiments easily in silico. One consideration in the current
study is that the process of Bax-activation is examined with
the polymerization of activated Bax abolished.
Bax-activation: a core module of bistability
An important means to study a complex network is to dissect
it into small elementary modules (1). The core module of
Bax-activation was the initial focus. Experimental evidence
suggests a self-ampliﬁcation process of Bax/Bak-activation
produced by BH3-only proteins (30,51). Cells can generate
more activated Bax after initial activation of a few Bax
molecules and there is always a lag between the initial Bax-
activation and the ﬁrst detectable MOMP. Bax/Bak auto-
activation was proposed to be one possible explanation,
although in vivo evidence is still lacking (51). An alternative
explanation is based on the interaction network of Bcl-2
family proteins. Bax, Activator, and Bcl2 constitute a positive-
feedback loop as shown in Fig. 1. Once Bax is activated, it
can bind Bcl2 competitively to free Activator, which will in
turn activate more Bax and amplify this process. In Fig. 3, a
and b, the second increase of Activator and AcBax mono-
mers indicates this self-ampliﬁcation process. It is well known
that nonlinear positive feedback can lead to bistability, a
typical kind of bioswitch (52). This raises the question of
whether the positive feedback here would be strong enough
to make the core module of Bax-activation bistable.
ODE model
The core module of Bax-activation is ﬁrst constructed using
ODEs in a deterministic way (see Model and Methods). For
simplicity, translocation of Activator is taken as the stimuli
F (F1¼ F3¼ 0, F2 varies from 0 to 1). We ﬁrst performed bi-
furcation analysis with F as the bifurcation parameter (Fig. 5).
This module shows the desired bistability: two stable
steady states coexist in a certain range of bifurcation param-
eter F, whereas outside this interval only a single steady state
exists. As indicated in Fig. 5, there is an off-state in which
the amount of total AcBax (monomer forms added to AcBax
in polymer forms) is very low (near zero), and an on-state
with a high level of Bax-activation. Another steady state ex-
ists between them but it is unstable and any perturbation will
send this system either up to the on-state or down to the off-
state. The arrows indicate the direction of evolution of the
level of Bax-activation, starting from any region of the diagram.
To test whether bistability is an inherent character of
the core module of Bax-activation, parameters were varied
FIGURE 3 CA and ODEs modeling of the mi-
tochondrial apoptosis regulatory network. The com-
bined signal of apoptosis rapidly diffuses into the
equilibrium system of initial condition. The con-
centration proﬁles of (a) Act, Ena, (b) AcBax mono-
mer, Bax pore, and AcBaxCC, and (c) Bcl2 are
plotted versus the CA time steps. For comparison
reasons, similar kinetics of these molecules is plot-
ted as panels c–e separately with a standard best-ﬁt
ODE modeling of these reactions.
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systematically within a certain range (for example, k1 was
varied from 0.1 to 5.0, Fig. 6). The results reveal that bistability
exists in a large region of parameter space. Further analyses
with the translocation of Bax or Bcl2 as stimuli F and bi-
furcation parameters show bistability as well (Fig. 7).
The going-up and coming-down analysis with stimuli F as
the parameter is performed by solving the ODEs (using
MatLab 6.5): F is varied along two directions (going-up and
coming-down, the former with 2 3 104 mM InBax as ini-
tialization and the latter with 23 104 mM AcBax as initial-
ization) and the amounts of AcBax in ﬁnal steady states (we
calculated up to 50,000 steps) are plotted in Fig. 8 a. A hys-
teretic phenomenon exists during this simulation. In a system
that is initially inactive with increasing stimuli F, the ratio of
AcBax to Total Bax remains near zero until it passes a point
at;F ¼ 0.32, where a sudden jump is seen. However, when
we reduce the stimuli F back, additional decrease is needed
to set this system back to the inactive state. This result is
consistent with Fig. 5 in which the on-state loses its stability
with a sudden decrease of AcBax level when the stimuli
F comes below a restriction point F ¼ 0.15. Our results
indicate that a memory of the transient stimuli is produced
by the core module of Bax-activation.
CA modeling
Noise is an important factor in the function of biological
reaction networks, as simulation studies have abundantly
demonstrated (18,53). In real reaction systems, stochastic
ﬂuctuations of Bax-activation may destroy the bistable
behavior of the core module of Bax-activation effectively.
For instance, any perturbation of Bax-activation higher than
the unstable state will send the system up to the on-state from
the off-state. So, if the system is too sensitive to noise, no
bistability will exist. This raises a concern of whether bistability
exits if stochastic ﬂuctuations are taken into account. Here
CA modeling gives an opportunity to construct such a sto-
chastic model.
The interaction rules in Table 2 were modiﬁed to realize
the core module of Bax-activation (the rate of Bax-poly-
merization is set to zero). We performed simulations in a
grid of 50350 squares (a quarter of the MOM), on which we
uniformly scattered 800 AcBax (or InBax), 400 Bcl2, and
800 Other molecules as initialization. The amount of trans-
located Activator is taken as the apoptotic stimulus. Tem-
poral evolution of the amount of AcBax with the given
stimuli can be simulated. We performed going-up and coming-
down analysis as follows: stimuli were varied along two
directions (going-up and coming-down, the former with 800
InBax as initialization and the latter with 800 AcBax as
initialization) and the amounts of AcBax in ﬁnal steady states
(we calculated up to 30,000 steps) are plotted in Fig. 8 b.
FIGURE 4 Changes of the initial ratio of Bax to CC and relative pa-
rameters reverse the ratio of Bax pores to active CC. 3200 Bcl2, 500 InBax,
200 Activator, 80 Enabler, 100 CC, and 3200 other proteins scattered on the
MOM as the initial condition. K21 is enlarged to 100, K22 is reduced to 15.
Other constants are given the same as in Table 3. Active CC constitute the
major parts of the pores in this simulation.
FIGURE 5 Bifurcation diagram of the core module of Bax activation as
a function of the stimuli F. Translocation of Activator is taken as the stimuli
F (F1 ¼ F3 ¼ 0, F2 varies from 0 to 1). The limit points for saddle-node
bifurcation are at F ¼ 0.15 and 0.32. The arrows indicate the equilibrium
concentrations reached when starting from any point in the diagram.
FIGURE 6 Bifurcation diagram illustrating the role of k1. Bistability ex-
ists in a large region of parameter k1. Translocation of Activator is taken as
the apoptosis stimuli F (F1 ¼ F3 ¼ 0, F2 varies from 0 to 1).
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Increasing stimuli induce a sudden jump of the AcBax steady
level and it takes additional decreases of stimuli to bring the
system back to the off-state. Therefore, bistability of the core
module of Bax-activation exists in both our deterministic and
stochastic models.
Coupling with Bax-polymerization
The bistable character of Bax-activation can relay a digital,
all-or-none signal to downstream events, e.g., MAC forma-
tion and MOMP. It is therefore proposed to be a possible
explanation for the switchlike behavior of apoptosis. How-
ever, there still remain two questions: ﬁrst, the on-state and
off-state of the Bax-activation can be realized only in a
limited parameter range, whereas outside of this range only
one of them prevails. It is uncertain whether parameter
values in physiological conditions would meet these restric-
tive constraints to make the module bistable. Second, the
bistable module of Bax-activation can act as a toggle switch
that is bidirectional, but this is not the case in apoptosis
induction. In other words, the module of Bax-activation lacks
irreversibility. These questions indicate that bistability of the
Bax-activation module is unlikely to be the sole mechanism
behind bioswitching of apoptosis induction.
Bax-polymerization into clusters, which could represent
protein-conducting pores, is the very end of the MOMP reg-
ulatory network (34). Thus both models mentioned above are
extended to study the effects of Bax-polymerization on the
dynamics of Bax-activation. In the ODE model, four AcBax
are assumed to aggregate into a tetramer and this process is
set to be irreversible. The strength of CAmodeling was taken
to enable more realistic modeling where AcBax can aggre-
gate into big clusters in a partly reversible process (for de-
tails, see Table 3). Again this was applied in the going-up
and coming-down analysis to get the dynamics of the Bax-
activation.
The cooperativity of Bax-polymerization can play a cen-
tral role in providing a decisive and irreversible transition in
Bax-activation against noise. In the ODE model (Fig. 9 a),
F is increased from 0 to 1 and upon passing a restriction
point, the amount of AcBax is lifted with a sudden jump in a
similar pattern as in Fig. 8 a. However, it cannot be re-
covered to an off-state even when F has been reduced to 0. A
transition from a toggle switch to a one-way switch takes
place when Bax-polymerization is incorporated to the core
module of Bax-activation. This one-way switch mechanism
can give a reasonable explanation for the irreversibility of
apoptosis induction. Another apparent difference is that the
AcBax level of the on-state is lifted to a higher level when
coupled with Bax-polymerization. With respect to robustness
against noise, this scenario has advantages over the situation
where the AcBax level of the on-state is lower because the
barrier that separates the off-state and on-state of Bax-
activation is now enlarged. All these make a robust one-way
switch of Bax-activation. A similar conclusion can also be
drawn from the results of the CA simulation (Fig. 9 b).
FIGURE 7 The module of Bax activation shows
bistabilities with the concentrations of (a) total Bax and
(b) total Bcl2 as the bifurcation parameters. (a) Translo-
cation of Bax is taken as the stimuli F (F2 ¼ F3 ¼ 0, F1
varies from 0 to 1). Actmito ¼ 0.43 104 mM, Baxmito ¼ 0
mM, Bcl2mito ¼ 13 104 mM, and Baxcytosol ¼ 23 104
mM are set as initial conditions. (b) Translocation of Bcl2
is taken as the stimuli F (F1 ¼ F2 ¼ 0, F3 varies from 0 to
1). Actmito ¼ 0.3 3 104 mM, Baxmito ¼ 2 3 104 mM,
Bcl2mito¼ 0 mM, and Bcl2cytosol¼ 13 104 mM are set as
initial condition.
FIGURE 8 Going-up and coming-down analysis with
stimuli F as parameter of the core module of Bax
activation. (a) In the ODEs modeling of the core module
of Bax activation, the amount of Activator, which repre-
sents the stimuli F (F1 ¼ F3 ¼ 0, F2 varies from 0 to 1), is
varied along two directions (going-up and coming-down)
and the AcBax numbers of ﬁnal steady states are plotted
versus F. (b) In the CAmodeling of the core module of Bax
activation, the amount of Activator, which represents the
stimuli F, is varied along two directions (going-up and
coming-down) and the AcBax numbers of ﬁnal steady
states are plotted versus the number of Activator (mean 6
SE of three independent simulation results). The reaction
rate constants are given as K1(300), K2(12),K3(800),K4(3),
K5(1000), K6(1), K7(500), and K8(300). All other rate
constants are set to be zero.
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CONCLUSION
In the present study, a systems biology approach was used to
understand dynamic processes in apoptosis induction. Both
ODE and CA models for mitochondrial apoptosis regulatory
network were developed based on qualitative and semiquan-
titative knowledge. A mitochondrial switch of Bax-activation
was proposed to be one of the mechanisms for the all-or-
none, irreversible behavior of cells in response to apoptotic
stimuli.
The purpose of this article is to look into the mitochondrial
apoptosis regulatory network. A self-ampliﬁcation process
of Bax-activation is reported in the literature and observed
during the CA simulation of the mitochondrial apoptosis reg-
ulatory network. This is due to a positive feedback embedded
in the interaction network of Bcl-2 family proteins. To
examine whether the positive feedback is strong enough to
bring about bistability, a core module of Bax-activation was
constructed by both ODE and CA modeling. Bifurcation
analysis and further studies revealed that bistability does
exist and seems to be an inherent characteristic of the core
module. It acts a toggle switch governing Bax-activation and
changes to a one-way switch with the cooperation of Bax-
polymerization, which strongly improves its robustness against
stochastic ﬂuctuations in physiological conditions.
From the simulation results, it can be concluded that the
remarkable activation and polymerization of Bax is a check-
point of the cell fate decision. The idea that the point at
which epithelial cells undergoing anoikis (a kind of apopto-
sis) have irreversibly committed to apoptosis equates to Bax-
activation is well in accord with this conclusion. Epithelial
cells can be rescued from anoikis even after Bax has dis-
tributed to the MOM, with a small part of them activated at
an early stage. However once Bax-polymerization occurs on
MOM, cells cannot be rescued (13,33). This implies that the
commitment of apoptosis occurs after Bax translocation but
before Bax-polymerization.
A further conclusion drawn from the simulation results is
that two states of cells could possibly coexist under a given
stimulus. This kind of bimodal population distribution is
common in bistable systems. A recent study by Nair et al.
(12) matches surprisingly well with this conclusion. Upon
examination of a population of cells undergoing oxidative
stress at single cell level, they detected a bifurcation of cell
fates into two states, either cell death or survival. The choice
of individual cells between these two exclusive states is sug-
gested to be a stochastic process, which is still lacking eluci-
dation. The mechanism proposed in this article gives a possible
explanation.
The stochastic modeling approach of cellular automaton
was displayed, which aided in uncovering the inherent func-
tion of the mitochondrial apoptosis regulatory network in a
stochastic way. The CA approach has been successfully em-
ployed for many years in various ﬁelds (54). Noise arises
because of its particulate or discrete nature. The stochasticity
also arises from the high level of reversibility for reactions.
CA-based simulations of biochemical networks, especially
for the apoptosis regulatory network, were scarce until re-
cently. Siehs et al. (20) simulated the time evolution of Bcl-2
family proteins using discrete time and space variables in a
Lattice Molecular Automaton (LMA). This was the ﬁrst at-
tempt to analyze the apoptosis regulatory mechanism in a
discrete, stochastic model. Their studies would have beenmore
realistic if they had considered more detailed interactions of
Bcl-2 family proteins. A crucial feature of our model that
differs from LMA is that it utilizes Brownian motion to
mimic the movements of molecules at the single mitochon-
drion level. This signiﬁcant dynamic simpliﬁcation potentially
allows very long timescales and large numbers of entities or
reactions to be modeled on a personal computer. Also, con-
struction of CA models is mainly based on qualitative and
semiquantitative knowledge of biochemical reactions, mol-
ecule numbers, and kinetic rates and can be easily expanded
into a complex model as long as more qualitative and quan-
titative data is obtained.
It should be noted that this study has only examined the
mitochondrial apoptosis regulatory network, which is a small
part of the complex network of apoptosis regulation. The
Bax-activation switch proposed here should not be the sole
mechanism of the all-or-none, irreversible character of ap-
optosis. A lot of work has already been done focused on
positive feedbacks (both short-term and long-term) and co-
operativities that can give rise to bistability. These upstream
and downstream events should undoubtedly be described to
gain a systematic understanding of this complex network.
Furthermore, the simulations performed here are taken at
FIGURE 9 Coupling to the Bax polymerization makes a
one-way-switch. (a) Extended ODE model considering
Bax polymerization. The amount of Activator, which
represents the stimuli F (F1 ¼ F3 ¼ 0, F2 varies from 0 to
1), is varied along two directions (going-up and coming-
down) and the AcBax numbers of ﬁnal steady states are
plotted versus F. (b) Extended CA model, given is the
mean 6 SE of three independent simulation results.
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single mitochondrion level and the copy numbers of different
proteins are deﬁnite. However, most experimental studies
have been performed using a population of cells, with dif-
ferent number of mitochondria in each cell with diverse copy
numbers of different proteins. This kind of system noise is
neglected in our models. Another limitation of this study is
that certain parameters used in the models are chosen to
reﬂect the experimentally known features. It is adequate
when only qualitative and semiquantitative characters are
discussed. However, we should expect that much of the nu-
merically known or estimated quantities can be made used
for exact construction of the network as more experimental
data are obtained.
Notwithstanding these limitations, our models take a very
important step for carrying out both deterministic and sto-
chastic modeling of the apoptosis regulatory network, in par-
ticular of mitochondrial regulatory events. This study suggests
that the module of Bax-activation coupling with Bax-
polymerization can act as a one-way switch governing the
all-or-none and irreversible behavior of apoptosis induction.
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